Prevalence of male pelvic dysfunction: results from the Turkish society of andrology male sexual health study group

dc.contributor.authorKendirci, M.
dc.contributor.authorAsci, R.
dc.contributor.authorYaman, O.
dc.contributor.authorCayan, S.
dc.contributor.authorOrhan, I.
dc.contributor.authorUsta, M. F.
dc.contributor.authorKadioglu, A.
dc.date.accessioned2026-08-12T17:48:07Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstractThe objective of this study was to determine the prevalence of male pelvic dysfunction (MPD) and its correlation in men 40years of age in a population-based study. This study was designed as a non-interventional, observational, cross-sectional field survey. Participating males of 40years were randomly selected from 19 provinces of Turkey. All participants were asked to complete a survey including data regarding demographics, socio-economic status, socio-cultural factors, medical and sexual history, current medications, comorbidities and three validated questionnaires assessing lower urinary tract symptoms (International Prostate Symptom Score), erectile dysfunction (International Index of Erectile Function) and ejaculatory behaviour (Male Sexual Health Questionnaire-4). MPD was defined by combining abnormal scores calculated from all three questionnaires. All data were analysed statistically and p<0.05 was accepted as significant. A total of 2730 males of 40years (mean, 54.2 +/- 10.6years) were enrolled in this study. The prevalence of MPD was calculated as 24.4% among all participants. The prevalence of MPD was lowest at age between 40 and 49years (9.1%) and highest at 70years (76.6%), exhibiting correlation with age. Each decade of increase in age was associated with a 3.4-fold increase in presence of MPD. At logistic regression analyses; age, diabetes, hypertension, dyslipidemia, cardiovascular disease, obesity and lower income were found to be independent predictors for increased prevalence of MPD. This study reports prevalence of MPD as 24.4% in males of 40years. Furthermore, age was found to be the main independent predictor of having MPD.
dc.description.sponsorshipPfizer
dc.description.sponsorshipFunding support for the study was provided by an unrestricted grant from Pfizer.
dc.identifier.doi10.1111/j.2047-2927.2013.00176.x
dc.identifier.endpage224
dc.identifier.issn2047-2919
dc.identifier.issn2047-2927
dc.identifier.issue2
dc.identifier.orcid0000-0002-1587-0688
dc.identifier.orcid0000-0002-2119-8963
dc.identifier.pmid24357639
dc.identifier.scopus2-s2.0-84894327260
dc.identifier.scopusqualityQ1
dc.identifier.startpage219
dc.identifier.urihttps://doi.org/10.1111/j.2047-2927.2013.00176.x
dc.identifier.urihttps://hdl.handle.net/11508/61306
dc.identifier.volume2
dc.identifier.wosWOS:000331696100009
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofAndrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectbenign prostatic hyperplasia
dc.subjectejaculatory dysfunction
dc.subjecterectile dysfunction
dc.subjectlower urinary tract symptoms
dc.subjectmale pelvic dysfunction
dc.subjectmen's health
dc.titlePrevalence of male pelvic dysfunction: results from the Turkish society of andrology male sexual health study group
dc.typeArticle

Dosyalar